510(k) device
The Inhibitor, Model 001
Melmedtronics, Inc. · Masker, Tinnitus (KLW, Class II) · First FDA decision Jun 29, 2007, newest Jun 29, 2007Tinnitus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
252
Naming "Inhibitor"
MAUDE reports
10
Brand "Inhibitor", since 2015
PubMed studies
857,580
Mentioning "Inhibitor"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing The Inhibitor, Model 001
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- THE INHIBITOR, MODEL 001510(k)
K070648 · Decided Jun 29, 2007 · 113 days after receipt
Device type: Masker, Tinnitus (KLW) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Anti-Inhibitor Coagulant Complex (AICC)National determinationOn the books110.3Updated Apr 17, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Inhibitor", any status and sponsor, newest update first.
- A Phase 2 Study of Dynamic BH3 Profiling (DBP) Guided Combination Therapy in Subjects With R/R AMLNot yet recruiting
Dana-Farber Cancer InstituteAcademic, hospital or other
NCT07949370 · 40 participants (planned) · Start Mar 6, 2027 · Primary completion Dec 31, 2029
Device: Dynamic BH3 Profiling · For: Relapsed or Refractory Acute Myeloid Leukemia (AML)
Sites: Boston, Massachusetts · 2 sites in all
Sun Yat-sen UniversityAcademic, hospital or other
NCT07947342 · 43 participants (planned) · Start Oct 20, 2026 · Primary completion Oct 2028
Device: Blank microspheres · For: Hepatocellular Carcinoma; Liver Neoplasms
Sites: Guangzhou, China
Northwell HealthAcademic, hospital or other
NCT05643235 · 50 participants (planned) · Start Jan 1, 2023 · Primary completion Dec 1, 2027
Device: Medtronic LINQ-2 Insertable Cardiac Monitor (ILR) · For: Atrial Fibrillation; Supraventricular Arrhythmia; Ventricular Arrhythmias and Cardiac Arrest and 2 more
Sites: New Hyde Park, New York
249 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Inhibitor", and for the whole product code for context.
This brand
10 reports: 10 malfunction, 0 injury, 0 death
Whole product code KLW
4 reports: 1 malfunction, 3 injury, 0 death
Newest reports for this brand
- MEDLINE FOG INHIBITOR WITH SPONGEMalfunction
3002750084-2025-00039 · Received Aug 13, 2025
Device type: Anti Fog Solution And Accessories, Endoscopy (OCT)
Device problem as coded: Unsealed Device Packaging
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2618282-2024-00131 · Received Sep 18, 2024 · Event dated Aug 20, 2024
Device type: Tubes, Vials, Systems, Serum Separators, Blood Collection (JKA)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- MEDLINE FOG INHIBITOR WITH SPONGE NONFB100Malfunction
ASPEN SURGICAL PRODUCTS, CALEDONIA
1836161-2024-00001 · Received Jan 30, 2024 · Event dated Jan 11, 2024
Device type: Anti Fog Solution And Accessories, Endoscopy (OCT)
Device problem as coded: Unsealed Device Packaging
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Inhibitor"[tiab]. The summary above synthesizes these.
- Editorial: C1 inhibitor deficiency and angioedema.
Farkas H, Germenis AE, Longhurst H · Front Allergy · 2022Editorial
- [Not Available].
Chauvet J, Acher R · FEBS Lett · 1968
- Anti-C1-Inhibitor Autoantibody Detection by ELISA.
Suffritti C, Caccia S, Berra S, et al. · Methods Mol Biol · 2021
- C1 inhibitor: quantification and purification.
Varga L, Dobó J · Methods Mol Biol · 2014Research Support, Non-U.S. Gov't
- Inhibitor Trapping in Kinases.
Spassov DS, Atanasova M, Doytchinova I · Int J Mol Sci · 2024
- A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding.
Fleming CL, Sandoz PA, Inghardt T, et al. · Angew Chem Int Ed Engl · 2019Research Support, Non-U.S. Gov't
- Arthropathy in inhibitor patients: differences in the joint status.
Hoots WK · Semin Hematol · 2008Research Support, Non-U.S. Gov't, Review
- Pearls and pitfalls in factor inhibitor assays.
Adcock DM, Favaloro EJ · Int J Lab Hematol · 2015Review
- Recent Progress of Polymeric Corrosion Inhibitor: Structure and Application.
Wang X, Liu S, Yan J, et al. · Materials (Basel) · 2023Review
- A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib-resistant ROR1+ CLL cells.
Ghaderi A, Okhovat MA, Wikanthi LSS, et al. · EJHaem · 2021
- C1 inhibitor cross-linking by tissue transglutaminase.
Hauert J, Patston PA, Schapira M · J Biol Chem · 2000Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
Other devices of this type
Also filed under product code KLW.
- Tinnitus Sound Generator ModuleGN Hearing A/S · 510(k) 2020
- Tinnitus Sound Generator ModuleGn Resound A/S · 510(k) 2015
- Multiflex Tinnitus TechnologyStarkey Laboratories, Inc. · 510(k) 2020
- SoundCure Serenade Tinnitus Treatment SystemSoundcure, Inc. · 510(k) 2015
- Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation · 510(k) 2026
- Tinnitus TherapySivantos GmbH · 510(k) 2026
- Peace N Quiet (0.7.0)Pnq Health · 510(k) 2024
- Tinearity G1 (6103)Duearity AB · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.